Applications of Green Carbon Dots in Personalized Diagnostics for Precision Medicine.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI, [2000-

Precision Medicine*/methods ; Carbon*/chemistry ; Quantum Dots*/chemistry; Humans

Green carbon dots (GCDs) have emerged as a revolutionary tool in precision medicine, offering transformative capabilities for personalized diagnostics and therapeutic strategies. Their unique optical and biocompatible properties make them ideal for non-invasive imaging, real-time monitoring, and integration with genomics, proteomics, and bioinformatics, enabling accurate diagnosis and tailored treatments based on patients' genetic and molecular profiles. This study explores the potential of GCDs in advancing individualized patient care by examining their applications in precision medicine. It evaluates their utility in non-invasive diagnostic imaging, targeted therapy delivery, and the formulation of personalized treatment plans, emphasizing their interaction with advanced genomic, proteomic, and bioinformatics platforms. GCDs demonstrated exceptional versatility in enabling precise diagnostics and delivering targeted therapies. Their integration with cutting-edge technologies showed significant promise in crafting personalized treatment strategies, enhancing their functionality and effectiveness in real-time monitoring and patient-specific applications. The findings underscore the pivotal role of GCDs in reshaping healthcare by advancing precision medicine and improving patient outcomes. The ongoing development and integration of GCDs with emerging technologies promise to further enhance their capabilities, paving the way for more effective, individualized medical care.

Chem Rev. 2014 Jun 25;114(12):6130-78. (PMID: 24779710)
ACS Appl Bio Mater. 2024 Dec 16;7(12):8149-8162. (PMID: 39526921)
Hastings Cent Rep. 2016 Sep;46(5):21-33. (PMID: 27649826)
J Fluoresc. 2024 Dec 16;:. (PMID: 39680341)
Nat Commun. 2021 Apr 23;12(1):2425. (PMID: 33893275)
Bioinorg Chem Appl. 2022 Apr 10;2022:9303703. (PMID: 35440939)
Beilstein J Nanotechnol. 2022 Oct 5;13:1068-1107. (PMID: 36262178)
Nat Prod Bioprospect. 2023 Nov 13;13(1):51. (PMID: 37953431)
J Nanobiotechnology. 2021 Oct 13;19(1):320. (PMID: 34645456)
Cell. 2021 Jan 21;184(2):370-383.e13. (PMID: 33333023)
Int J Mol Sci. 2021 Oct 29;22(21):. (PMID: 34769212)
Polymers (Basel). 2020 May 14;12(5):. (PMID: 32423073)
J Mater Chem B. 2017 Dec 7;5(45):8904-8924. (PMID: 32264117)
Nat Rev Drug Discov. 2021 Feb;20(2):101-124. (PMID: 33277608)
ACS Appl Mater Interfaces. 2024 Dec 4;16(48):65955-65969. (PMID: 39561278)
Discov Nano. 2024 Dec 17;19(1):205. (PMID: 39681796)
ACS Appl Bio Mater. 2024 Apr 15;7(4):2086-2127. (PMID: 38512809)
Cell. 2020 Apr 2;181(1):151-167. (PMID: 32243788)
J Mater Chem B. 2017 Jun 7;5(21):3794-3809. (PMID: 32264241)
Small. 2024 Nov;20(47):e2403653. (PMID: 39165080)
RSC Adv. 2020 Jun 23;10(40):23861-23898. (PMID: 35517370)
Small. 2024 Jul;20(30):e2311013. (PMID: 38372007)
Small Sci. 2022 May 08;2(6):2200012. (PMID: 40213786)
ACS Omega. 2022 Oct 26;7(44):39586-39602. (PMID: 36385871)
ACS Omega. 2021 Jan 21;6(4):3232-3237. (PMID: 33553940)
Chem Rev. 2015 Jun 10;115(11):4744-822. (PMID: 26012488)
Small. 2024 Jun;20(25):e2310728. (PMID: 38229573)
ACS Omega. 2020 May 05;5(20):11248-11261. (PMID: 32478212)
Chem Soc Rev. 2015 Jul 21;44(14):4517-46. (PMID: 25747236)
Chem Rev. 2016 Mar 9;116(5):3436-86. (PMID: 26865551)
Nat Rev Clin Oncol. 2021 Sep;18(9):547-557. (PMID: 33911215)
J Adv Res. 2025 Jan;67:133-159. (PMID: 38320729)
Small. 2023 Aug;19(31):e2206671. (PMID: 36479832)
Chem Soc Rev. 2021 Nov 1;50(21):11979-12012. (PMID: 34515721)
J Fluoresc. 2023 Sep;33(5):1971-1979. (PMID: 36933122)
Int J Nanomedicine. 2021 Jul 23;16:5003-5016. (PMID: 34326638)
J Funct Biomater. 2023 Jan 02;14(1):. (PMID: 36662074)
Nanoscale. 2023 Sep 1;15(34):13858-13885. (PMID: 37535002)
Int J Nanomedicine. 2022 May 02;17:1951-1970. (PMID: 35530976)
Adv Sci (Weinh). 2020 Apr 29;7(12):2000420. (PMID: 32596126)
ACS Nano. 2015 Nov 24;9(11):11455-61. (PMID: 26458137)
Colloids Surf B Biointerfaces. 2024 Sep;241:114032. (PMID: 38905812)
Curr Pharm Des. 2021;27(17):2068-2075. (PMID: 33618640)
J Control Release. 2022 Jan;341:285-299. (PMID: 34822910)
Genes (Basel). 2021 May 23;12(6):. (PMID: 34070957)
Biosensors (Basel). 2023 Feb 04;13(2):. (PMID: 36831992)
Luminescence. 2024 Aug;39(8):e4849. (PMID: 39099225)
Small. 2019 Nov;15(48):e1901803. (PMID: 31240816)
Turk J Pharm Sci. 2018 Aug;15(2):219-230. (PMID: 32454664)
J Clin Med. 2020 Jan 03;9(1):. (PMID: 31947757)
Nat Rev Urol. 2021 Feb;18(2):104-114. (PMID: 33432181)
Small Methods. 2023 Feb;7(2):e2201313. (PMID: 36599700)
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):. (PMID: 33495337)
ACS Appl Bio Mater. 2021 Sep 20;4(9):7280-7289. (PMID: 35006957)
J Fluoresc. 2021 Sep;31(5):1241-1250. (PMID: 34181146)
Sci Total Environ. 2020 Aug 20;731:138049. (PMID: 32408201)
Cancers (Basel). 2021 Apr 21;13(9):. (PMID: 33919096)
Nat Rev Drug Discov. 2019 Mar;18(3):175-196. (PMID: 30622344)

Keywords: GCDs; drug delivery systems; genomics; proteomics; theranostics

7440-44-0 (Carbon)

Date Created: 20250417 Date Completed: 20250417 Latest Revision: 20250419

20250419

PMC11988419

10.3390/ijms26072846

40243410